Literature DB >> 25802012

Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.

Aurélie Jaspers1, Frédéric Baron1,2, Johan Maertens3, Bernard De Prijck1,4, Rik Schots5, Christophe Bonnet1, Kaoutar Hafraoui1, Évelyne Willems1, Sophie Servais1,2, Georges Fillet1, Yves Beguin1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25802012     DOI： 10.1002/ajh.24013

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.

Authors:  Michelle Pirotte; Marianne Fillet; Laurence Seidel; Aurélie Jaspers; Fréderic Baron; Yves Beguin
Journal:  Am J Hematol       Date:  2021-08-24       Impact factor: 13.265

Review 2.  Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency.

Authors:  Iain C Macdougall; Josep Comin-Colet; Christian Breymann; Donat R Spahn; Ioannis E Koutroubakis
Journal:  Adv Ther       Date:  2020-04-15       Impact factor: 3.845
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.